We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$47.8B
AUM Growth
+$3.07B
(+6.9%)
Cap. Flow
-$507M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
17.74%
Holding
1,131
New
130
Increased
292
Reduced
306
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$526M |
| 2 |
Ally Financial
ALLY
|
+$198M |
| 3 |
CSX Corp
CSX
|
+$191M |
| 4 |
NetEase
NTES
|
+$173M |
| 5 |
Norwegian Cruise Line
NCLH
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$262M |
| 2 |
CVS Health
CVS
|
+$240M |
| 3 |
Mastercard
MA
|
+$204M |
| 4 |
McKesson
MCK
|
+$201M |
| 5 |
Molson Coors Class B
TAP
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Communication Services | 13.94% |
| 3 | Technology | 12.15% |
| 4 | Financials | 10.5% |
| 5 | Energy | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Pediatrix Medical
MD
$2.17B
| $8.17M | 0.02% |
140,578
-3,500
| -2% | -$206K |
|
|
MRD
377
DELISTED
MEMORIAL RESOURCE DEV CORP COM STK (DE)
MRD
| $8.17M | 0.02% |
+335,344
| New | +$8.07M |
|
378
Petrobras
PBR
$120B
| $8.08M | 0.02% |
552,285
-63,086
| -10% | -$919K |
|
379
Quanta Services
PWR
$85.9B
| $7.97M | 0.02% |
230,540
-17,899
| -7% | -$620K |
|
380
SS&C Technologies
SSNC
$19.2B
| $7.87M | 0.02% |
356,090
-256,476
| -42% | -$5.31M |
|
381
Dover
DOV
$26.7B
| $7.86M | 0.02% |
107,011
-3,216
| -3% | -$225K |
|
382
Synaptics
SYNA
$4.17B
| $7.8M | 0.02% |
86,062
-119,778
| -58% | -$8.12M |
|
383
Acco Brands
ACCO
$395M
| $7.76M | 0.02% |
1,210,419
+142,921
| +13% | +$874K |
|
384
Oceaneering
OII
$4.71B
| $7.75M | 0.02% |
+99,207
| New | +$7.28M |
|
|
TIBX
385
DELISTED
TIBCO SOFTWARE INC
TIBX
| $7.72M | 0.02% |
382,669
-735,831
| -66% | -$14.7M |
|
386
Boeing
BA
$168B
| $7.68M | 0.02% |
60,336
-520
| -0.9% | -$67.9K |
|
|
EV
387
DELISTED
Eaton Vance Corp.
EV
| $7.66M | 0.02% |
202,637
+90,527
| +81% | +$3.34M |
|
388
Emcor
EME
$30.4B
| $7.6M | 0.02% |
170,781
-13,908
| -8% | -$631K |
|
389
Murphy Oil
MUR
$5.49B
| $7.51M | 0.02% |
113,001
-3,512
| -3% | -$220K |
|
390
Home Depot
HD
$338B
| $7.51M | 0.02% |
92,733
+40,125
| +76% | +$3.17M |
|
391
Coca-Cola
KO
$390B
| $7.48M | 0.02% |
176,723
+109,955
| +165% | +$4.46M |
|
392
Standard Motor Products
SMP
$909M
| $7.41M | 0.02% |
165,961
-4,300
| -3% | -$174K |
|
393
Tanger
SKT
$4.84B
| $7.41M | 0.02% |
211,844
-18,025
| -8% | -$641K |
|
|
IPG
394
DELISTED
Interpublic Group of Companies
IPG
| $7.4M | 0.02% |
379,358
| – | – |
|
395
Meta Platforms (Facebook)
META
$1.49T
| $7.39M | 0.02% |
109,900
+35,396
| +48% | +$2.18M |
|
|
SPIL
396
DELISTED
Siliconware Precision Industries Co Ltd
SPIL
| $7.35M | 0.02% |
894,885
+273,287
| +44% | +$2.05M |
|
397
East-West Bancorp
EWBC
$17.9B
| $7.26M | 0.02% |
207,496
-180,693
| -47% | -$6.28M |
|
|
RPT.PRD
398
DELISTED
RPT Realty 7.25% Series D Cumulative Convertible Perpetual Preferred Shares of Beneficial Interest
RPT.PRD
| $7.21M | 0.02% |
117,756
+17,756
| +18% | +$1.08M |
|
399
TotalEnergies
TTE
$192B
| $7.15M | 0.01% |
99,058
+1,765
| +2% | +$124K |
|
|
RTN
400
DELISTED
Raytheon Company
RTN
| $7.05M | 0.01% |
76,424
-24,001
| -24% | -$2.33M |
|
Similar funds
QCM
Lazard Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Lazard Asset Management held 1,131 positions worth $47.8B, up 6.9% from $44.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Lazard Asset Management's Q2 2014 filing shows 130 new, 292 increased, 306 reduced and 143 closed positions. Its largest new stake was Ally Financial: 8,153,883 shares worth $195M. The largest sale was Gilead Sciences, an estimated $262M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Communication Services and Technology.
- Lazard Asset Management's largest Q2 2014 buy was Ally Financial: 8,153,883 shares worth $195M.
- Lazard Asset Management added most to Teva Pharmaceuticals in Q2 2014, an estimated $526M increase.
- Lazard Asset Management's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $262M.
- Lazard Asset Management fully exited Mastercard in Q2 2014, selling an estimated $204M.
- Lazard Asset Management's ten largest holdings make up 18% of its $47.8B portfolio in Q2 2014.
- Lazard Asset Management opened 130 new positions and closed 143 in Q2 2014.
- Lazard Asset Management's portfolio value rose 6.9% quarter-over-quarter to $47.8B.
Based on Lazard Asset Management's 13F filing for Q2 2014, filed 12 Aug 2014.